ProShare Advisors LLC
- SEC CIK
- 0001357955
- Latest filing
- Aug 11, 2026
ZVRA holding history
Zevra Therapeutics, Inc. in every 13F filed by ProShare Advisors LLC, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.
ZVRA overviewAll 13F holders of ZVRAFull Q2 2026 holdings
- Shares (Q2 2026)
- 0
- Sold out in Q2 2026
- Value
- $0
- % of portfolio
- 0.0%
- Quarters held
- 8
- Since Q4 2021
| Quarter | Shares | Value | % of portfolio | Share change | Action | All holders |
|---|---|---|---|---|---|---|
| Q2 2026 | 0 | $0 | 0.0% | −10,594−100.0% | Sold out | Holders |
| Q1 2026 | 10,594 | $98.7K | <0.1% | −2,075−16.4% | Reduced | Holders |
| Q4 2025 | 12,669 | $113.5K | <0.1% | +1,390+12.3% | Added | Holders |
| Q3 2025 | 11,279 | $107.3K | <0.1% | −1,892−14.4% | Reduced | Holders |
| Q2 2025 | 13,171 | $116.0K | <0.1% | −851−6.1% | Reduced | Holders |
| Q1 2025 | 14,022 | $105.0K | <0.1% | −3,403−19.5% | Reduced | Holders |
| Q4 2024 | 17,425 | $145.3K | <0.1% | +17,425 | New | Holders |
| Q3 2024 | 0 | $0 | 0.0% | −4,871−100.0% | Sold out | Holders |
| Q2 2024 | 4,871 | $23.9K | <0.1% | +4,871 | New | Holders |
| Q1 2022 | 0 | $0 | 0.0% | −11,452−100.0% | Sold out | Holders |
| Q4 2021 | 11,452 | $100.0K | <0.1% | +11,452 | New | Holders |